224 related articles for article (PubMed ID: 20526650)
21. A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas.
Kumthekar P; Grimm S; Chandler J; Mehta M; Marymont M; Levy R; Muro K; Helenowski I; McCarthy K; Fountas L; Raizer J
J Neurooncol; 2017 Jul; 133(3):589-594. PubMed ID: 28510787
[TBL] [Abstract][Full Text] [Related]
22. Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma.
Ishikawa E; Muragaki Y; Yamamoto T; Maruyama T; Tsuboi K; Ikuta S; Hashimoto K; Uemae Y; Ishihara T; Matsuda M; Matsutani M; Karasawa K; Nakazato Y; Abe T; Ohno T; Matsumura A
J Neurosurg; 2014 Sep; 121(3):543-53. PubMed ID: 24995786
[TBL] [Abstract][Full Text] [Related]
23. Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas.
Minniti G; Scaringi C; De Sanctis V; Lanzetta G; Falco T; Di Stefano D; Esposito V; Enrici RM
J Neurooncol; 2013 Jan; 111(2):187-94. PubMed ID: 23129347
[TBL] [Abstract][Full Text] [Related]
24. A multicenter prospective observational study of the conformity of temozolomide prescriptions in France.
Tilleul P; Brignone M; Hassani Y; Labrande C; Pedeboscq S; Gensollen S; Lahille B; Exinger D; Bertholle V; Billard M; Charlety D; Prebay D; Pinguet F; Taillibert S; Cartalat S; Chinot O; Borget I;
Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):828-34. PubMed ID: 22419509
[TBL] [Abstract][Full Text] [Related]
25. Radiation combined with temozolomide contraindicated for young adults diagnosed with anaplastic glioma.
Yang P; Zhang C; Cai J; You G; Wang Y; Qiu X; Li S; Wu C; Yao K; Li W; Peng X; Zhang W; Jiang T
Oncotarget; 2016 Nov; 7(48):80091-80100. PubMed ID: 27590514
[TBL] [Abstract][Full Text] [Related]
26. Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial.
Malmström A; Poulsen HS; Grønberg BH; Stragliotto G; Hansen S; Asklund T; Holmlund B; Łysiak M; Dowsett J; Kristensen BW; Söderkvist P; Rosell J; Henriksson R;
Acta Oncol; 2017 Dec; 56(12):1776-1785. PubMed ID: 28675067
[TBL] [Abstract][Full Text] [Related]
27. Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas.
Chamberlain MC
Expert Rev Neurother; 2010 Oct; 10(10):1537-44. PubMed ID: 20925470
[TBL] [Abstract][Full Text] [Related]
28. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.
Jalali R; Raut N; Arora B; Gupta T; Dutta D; Munshi A; Sarin R; Kurkure P
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):113-8. PubMed ID: 19647954
[TBL] [Abstract][Full Text] [Related]
29. MRI and thallium-201 SPECT in the prediction of survival in glioma.
Vos MJ; Berkhof J; Hoekstra OS; Bosma I; Sizoo EM; Heimans JJ; Reijneveld JC; Sanchez E; Lagerwaard FJ; Buter J; Noske DP; Postma TJ
Neuroradiology; 2012 Jun; 54(6):539-46. PubMed ID: 21755329
[TBL] [Abstract][Full Text] [Related]
30. Extended adjuvant temozolomide for treatment of newly diagnosed glioblastoma multiforme.
Roldán Urgoiti GB; Singh AD; Easaw JC
J Neurooncol; 2012 May; 108(1):173-7. PubMed ID: 22382781
[TBL] [Abstract][Full Text] [Related]
31. A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy.
Gilbert MR; Friedman HS; Kuttesch JF; Prados MD; Olson JJ; Reaman GH; Zaknoen SL
Neuro Oncol; 2002 Oct; 4(4):261-7. PubMed ID: 12356356
[TBL] [Abstract][Full Text] [Related]
32. The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma.
Sher DJ; Henson JW; Avutu B; Hochberg FH; Batchelor TT; Martuza RL; Barker FG; Loeffler JS; Chakravarti A
J Neurooncol; 2008 May; 88(1):43-50. PubMed ID: 18231723
[TBL] [Abstract][Full Text] [Related]
33. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
[TBL] [Abstract][Full Text] [Related]
34. Feasibility of preirradiation temozolomide in cases of high-grade gliomas: Our experience and review of literature.
Arora S; Rathi AK; Singh K; Ansari FA
J Cancer Res Ther; 2023; 19(2):221-227. PubMed ID: 37006062
[TBL] [Abstract][Full Text] [Related]
35. Expression of O6-methylguanine-deoxyribose nucleic acid methyltransferase and temozolomide response in a patient with a malignant spinal cord astrocytoma. Case report.
Rovin RA; Winn R
J Neurosurg Spine; 2007 May; 6(5):447-50. PubMed ID: 17542512
[TBL] [Abstract][Full Text] [Related]
36. [Contribution of temozolomide chemotherapy for intramedullary grade II spinal cord astrocytomas in adults: Our experience].
Chaskis E; Minichini V; Luce S; Devriendt D; Goldman S; De Witte O; Sadeghi N; Lefranc F
Neurochirurgie; 2017 Sep; 63(4):297-301. PubMed ID: 28882604
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
[TBL] [Abstract][Full Text] [Related]
38. Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients.
Silvani A; Eoli M; Salmaggi A; Lamperti E; Maccagnano E; Broggi G; Boiardi A
J Neurooncol; 2004 Jan; 66(1-2):203-8. PubMed ID: 15015788
[TBL] [Abstract][Full Text] [Related]
39. Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas.
Combs SE; Bischof M; Welzel T; Hof H; Oertel S; Debus J; Schulz-Ertner D
J Neurooncol; 2008 Sep; 89(2):205-10. PubMed ID: 18461281
[TBL] [Abstract][Full Text] [Related]
40. Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the "rescue" approach.
Perry JR; Rizek P; Cashman R; Morrison M; Morrison T
Cancer; 2008 Oct; 113(8):2152-7. PubMed ID: 18756530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
